News

The new agreement extends the Multikine collaboration to also cover South Korea, the Philippines, Australia and New Zealand. The licensing agreement initially focuses on the areas of head

Under this distribution agreement, Labtech will handle sales and service in the UK, Ireland and France of Fluxion’s BioFlux research tools for live cell image analysis in drug

The Phase II, US multi-center randomized, double-blind, placebo-controlled study, Mpex 302 is expected to enroll approximately 300 chronic obstructive pulmonary disease (COPD) patients to evaluate the safety, tolerability

This study is designed to compare glycemic control of a standardized liquid meal challenge and insulin pharmacokinetics (PK) after administration of each of four study drugs: Humulin R

The Phase II trial, called Explore Xa, is a multi-national, double-blind, dose-finding study that will enroll approximately 500 patients and assess three once-daily doses of betrixaban (40mg, 60mg,

The top-line results from the recently completed multi-center, randomized, double-blind, placebo-controlled Phase II trial indicated a statistically significant reduction in recurrences of C difficile associated diarrhea (CDAD) when

According to the company, the availability of AuroraSpectroscopy will provide Aurora breast magnetic resonance imaging (MRI) the capability to perform in vivo breast MR spectroscopy (MRS) and MR

The purpose of the trial is to evaluate whether ATI-5923 is superior to warfarin in its ability to maintain patients within a target therapeutic range of the level

The new medical center will be situated at Sonapur, in Al Ghusais. The Department of Health and Medical Services (DOHMS) expects the center to process 5,000 applications daily.